SCHEMBL8851563

SCHEMBL8851563

CC([NH])CCNC(=O)c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.65
SMN1; SMN2 Q16637 5/20 0.62
NPC1 O15118 5/20 0.62
RAB9A P51151 5/20 0.62
LMNA P02545 2/20 0.57
POLB P06746 1/20 0.57
NAAA Q02083 1/20 0.54
GAA P10253 1/20 0.53
KCNA5 P22460 1/20 0.52
PRSS1 P07477 1/20 0.51
CTSG P08311 1/20 0.51
CTRB1 P17538 1/20 0.51
CMA1 P23946 1/20 0.51
HPGD P15428 2/20 0.51
RECQL P46063 1/20 0.50
HDAC3 O15379 1/20 0.50
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC2 Q92769 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL496789 0.86 SMN1; SMN2 (0.81) EPHX2SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL27389698 0.83 EPHX2 (0.65) EPHX2SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL27790062 0.83 EPHX2 (0.65) EPHX2SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL6204191 0.81 EPHX2 (0.63) EPHX2SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL19303136 0.81 EPHX2 (0.63) EPHX2SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL10722901 0.81 EPHX2 (0.73) EPHX2SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL10099587 0.81 EPHX2 (0.63) EPHX2SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL27467294 0.80 EPHX2 (0.61) EPHX2SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL17225741 0.80 SMN1; SMN2 (0.77) EPHX2SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL10137831 0.79 SMN1; SMN2 (0.67) EPHX2SMN1; SMN2NPC1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5618814-A Trisubstituted pyrimido [5,4-d] pyrimidines for modulating multi-drug resistance and pharmaceutical compositions containing these compounds DR. KARL THOMAE GMBH (DE) 1997-04-08 US disclosed